Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD II: D-PLEX for Prevention of Post Abdominal Surgery Incisional Infection
NCT04411199Phase 3Completed
- Sponsor
- PolyPid Ltd.
- Start
- Dec 2020
- Primary completion
- Apr 2025
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of D-PLEX100 in surgical site infection (SSI), sponsored by PolyPid Ltd.. Started Dec 2020; status: completed.
02
Drugs
D-PLEX100
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04411199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411199.